C40.80 is a billable ICD-10 code used to specify a medical diagnosis of malignant neoplasm of overlapping sites of bone and articular cartilage of unspecified limb. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.
The following anatomical sites found in the Table of Neoplasms reference the parent code C40.8 of the current diagnosis code given the correct histological behavior: Neoplasm, neoplastic bone (periosteum) overlapping sites .
Unspecified diagnosis codes like C40.80 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Overlapping malignant neoplasm of bone and articular cartilage
- Overlapping malignant neoplasm of bone and articular cartilage of limb
- Overlapping primary malignant neoplasm of bone and articular cartilage of lower limb
- Overlapping primary malignant neoplasm of bone and articular cartilage of upper limb
Convert to ICD-9 Code
|Source ICD-10 Code||Target ICD-9 Code|
|C40.80||170.9 - Malig neopl bone NOS|
|Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.|
Table of Neoplasms
The parent code C40.8 of the current diagnosis code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
Cancer that starts in a bone is uncommon. Cancer that has spread to the bone from another part of the body is more common.
There are three types of bone cancer:
- Osteosarcoma - occurs most often between ages 10 and 19. It is more common in the knee and upper arm.
- Chondrosarcoma - starts in cartilage, usually after age 40
- Ewing's sarcoma - occurs most often in children and teens under 19. It is more common in boys than girls.
The most common symptom of bone cancer is pain. Other symptoms vary, depending on the location and size of the cancer. Surgery is often the main treatment for bone cancer. Other treatments may include amputation, chemotherapy, and radiation therapy. Because bone cancer can come back after treatment, regular follow-up visits are important.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
Primary Bone CancerLearn about the types of bone tumors and the methods used to diagnose and treat cancers that form from bone tissue.
[Learn More in MedlinePlus]
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)